Search Results for: blog

New Republican Governors Start Attack On Most Promising Stem Cell Research

Last Fall’s mid-term election brought into office several new Republican Governors who during their campaigns used strong, anti-embryonic stem (ES) cell research rhetoric. For example, then candidate for Governor of Wisconsin, Scott Walker (now the Governor) used some of the strongest language, which was ironic considering that human ES cells were first produced in Wisconsin …

New Republican Governors Start Attack On Most Promising Stem Cell Research Read More »

Contagious cancer: the allograft your dog doesn’t want

Can one creature directly give another creature cancer? It appears so in dogs and that cancer is highly contagious. When we think about transplants of cells, we think about hospitals and high-tech equipment used to give patients stem cells or other types of cells to help treat them for a disease. Generally cancer patients are …

Contagious cancer: the allograft your dog doesn’t want Read More »

A perspective on U.S. embryonic stem cell research from Israel

As we have blogged before, there are a host of different beliefs about embryonic stem cell research and about when life begins. This diversity of perspectives is sprinkled across the globe. Too often in the U.S. people take an ethnocentric view of this question, believing that everyone else should think the same as they do. …

A perspective on U.S. embryonic stem cell research from Israel Read More »

My Cancer: how I became an advocate too

IMG_0572

There is a kind of invisible cultural wall between patients such as cancer patients and biomedical scientists like me, but this wall does not have to exist and indeed it is a negative wall as patients, scientists, doctors, agencies, and advocates can achieve far more together than apart. But the wall is surprisingly strong. Last …

My Cancer: how I became an advocate too Read More »

From Point A to Point Z: thinking outside the box about stem cells

What is the best way to get new stem cell-based therapies to the millions of patients who need help? I would argue that this is the key question in the field of stem cell biology and regenerative medicine. Sometimes I think it is easy for folks to lose sight of that and fall into traps. …

From Point A to Point Z: thinking outside the box about stem cells Read More »

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness

advanced-cell-technology

The FDA has given Advanced Cell Technology (ACT) the go ahead to begin their clinical trial using retinal progenitor cells derived from hESC by clearing the company’s IND application, bringing hope to those with vision loss and even blindness. The trial will be a combined Phase I/II to treat Stargardt’s Macular Dystrophy and has huge …

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness Read More »

Why scientists must be advocates too: Jeff Sheehy

Jeff-Sheehy

CIRM Board Member, Jeff Sheehy, has a wonderful piece in Nature Medicine on why patient advocates play a critical role in decision making on research priorities (hat tip to Amy Adams who first blogged on Sheehy’s piece). Patient advocates bring a unique and valuable perspective to the table. Their role in guiding CIRM research funding …

Why scientists must be advocates too: Jeff Sheehy Read More »